Structural and Computational-Driven Molecule Design in Drug Discovery

This Special Issue aimed to provide deep mechanistic insights into strategies in structural dynamics studies and computational methods. The areas of research included but were not limited to the following: structural dynamics studies, computer-aided drug designs, molecular dynamic simulations, molec...

Повний опис

Збережено в:
Бібліографічні деталі
Формат: Online
Мова:Англійська
Опубліковано: MDPI - Multidisciplinary Digital Publishing Institute 2024
Предмети:
SAR
BBB
DFT
Онлайн доступ:ONIX_20240704_9783725810147_8
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
_version_ 1869517430790815744
collection Directory of Open Access Books
description This Special Issue aimed to provide deep mechanistic insights into strategies in structural dynamics studies and computational methods. The areas of research included but were not limited to the following: structural dynamics studies, computer-aided drug designs, molecular dynamic simulations, molecular docking, virtual screening, QSAR, and in silico ADMET analyses.
format Online
id doab-20.500.12854ir-139212
institution Directory of Open Access Books
language eng
publishDate 2024
publishDateRange 2024
publishDateSort 2024
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1392122024-07-04T09:28:16Z Structural and Computational-Driven Molecule Design in Drug Discovery Ciftci, Halil ?brahim Sever, Belgin Demirci, Hasan SARS-CoV-2 COVID-19 drug repositioning in silico studies E protein furan-1,3,4-oxadiazole hTYR hTYRP1 melanogenesis molecular docking MD simulations substituted phenylacetic acid Cu(II) carboxylates DNA binding enzymatic activity antioxidant activity bitter almond EGFR HER2 ADEMT molecular dynamic MM-PBSA Pd(II) complexes X-ray structure antibacterial activity antitumor activity in silico study benzofuran-1,3,4-oxadiazole tuberclosis Pks13 inhibitor ADMET study SAR artificial intelligence drug discovery AI-assisted content generation AI-limitations galactosides dengue virus antimicrobial dynamics ADMET chickpea bioactive peptides DPP-IV inhibitors in silico MRSA shikimate pathway dehydroquinate dehydratase virtual screening molecular dynamics computer-aided drug design AChE/BChE Alzheimer’s disease neurodegenerative disorders antioxidants donepezil melatonin neuroprotection SH-SY5Y Neuro-2a BBB MT1 and MT2 molecular dynamic simulations acetylcholinesterase zebrafish hepatitis B virus hepatitis C virus (+)-catechin 3-gallate ?-sitosterol KEGG protein–protein interactions cell-penetrating peptides drug conjugates biological membrane penetratin cyclic peptides explicit membrane model intracellular target Desmond in silico simulation protein kinase cancer neurodegenerative diseases covalent inhibitors ?-keto esters DFT docking LasR and LuxS quorum sensing natural bioactive compounds natural products network pharmacology ischemic stroke flavonoids terpenoids analgesic 5-acetamido-2-hydroxy benzoic acid ADME toxicity TRAF6 zinc finger RING domain X-ray crystallography structural biology Turkish light source “Turkish DeLight” molecular modelling pharmacokinetic determinants human acetylcholinesterase human butyrylcholinesterase human beta-secretase 1 cytotoxic iridoids dipole moment QSAR ligand-based design bigel Calophyllum inophyllum calanolide A piscean collagen tamanu oil drug design novel molecules encoder–decoder transformer quantitative estimate of drug-likeness (QED) validity reinforcement learning thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing This Special Issue aimed to provide deep mechanistic insights into strategies in structural dynamics studies and computational methods. The areas of research included but were not limited to the following: structural dynamics studies, computer-aided drug designs, molecular dynamic simulations, molecular docking, virtual screening, QSAR, and in silico ADMET analyses. 2024-07-04T09:28:11Z 2024-07-04T09:28:11Z 2024 book ONIX_20240704_9783725810147_8 9783725810147 9783725810130 https://directory.doabooks.org/handle/20.500.12854/139212 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/9207 https://mdpi.com/books/pdfview/book/9207 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-1013-0 10.3390/books978-3-7258-1013-0 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725810147 9783725810130 468 open access
spellingShingle SARS-CoV-2
COVID-19
drug repositioning
in silico studies
E protein
furan-1,3,4-oxadiazole
hTYR
hTYRP1
melanogenesis
molecular docking
MD simulations
substituted phenylacetic acid
Cu(II) carboxylates
DNA binding
enzymatic activity
antioxidant activity
bitter almond
EGFR
HER2
ADEMT
molecular dynamic
MM-PBSA
Pd(II) complexes
X-ray structure
antibacterial activity
antitumor activity
in silico study
benzofuran-1,3,4-oxadiazole
tuberclosis
Pks13 inhibitor
ADMET study
SAR
artificial intelligence
drug discovery
AI-assisted content generation
AI-limitations
galactosides
dengue virus
antimicrobial
dynamics
ADMET
chickpea
bioactive peptides
DPP-IV inhibitors
in silico
MRSA
shikimate pathway
dehydroquinate dehydratase
virtual screening
molecular dynamics
computer-aided drug design
AChE/BChE
Alzheimer’s disease
neurodegenerative disorders
antioxidants
donepezil
melatonin
neuroprotection
SH-SY5Y
Neuro-2a
BBB
MT1 and MT2
molecular dynamic simulations
acetylcholinesterase
zebrafish
hepatitis B virus
hepatitis C virus
(+)-catechin 3-gallate
?-sitosterol
KEGG
protein–protein interactions
cell-penetrating peptides
drug conjugates
biological membrane
penetratin
cyclic peptides
explicit membrane model
intracellular target
Desmond
in silico simulation
protein kinase
cancer
neurodegenerative diseases
covalent inhibitors
?-keto esters
DFT
docking
LasR and LuxS
quorum sensing
natural bioactive compounds
natural products
network pharmacology
ischemic stroke
flavonoids
terpenoids
analgesic
5-acetamido-2-hydroxy benzoic acid
ADME
toxicity
TRAF6
zinc finger
RING domain
X-ray crystallography
structural biology
Turkish light source “Turkish DeLight”
molecular modelling
pharmacokinetic determinants
human acetylcholinesterase
human butyrylcholinesterase
human beta-secretase 1
cytotoxic iridoids
dipole moment
QSAR
ligand-based design
bigel
Calophyllum inophyllum
calanolide A
piscean collagen
tamanu oil
drug design
novel molecules
encoder–decoder
transformer
quantitative estimate of drug-likeness (QED)
validity
reinforcement learning
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing
Structural and Computational-Driven Molecule Design in Drug Discovery
title Structural and Computational-Driven Molecule Design in Drug Discovery
title_full Structural and Computational-Driven Molecule Design in Drug Discovery
title_fullStr Structural and Computational-Driven Molecule Design in Drug Discovery
title_full_unstemmed Structural and Computational-Driven Molecule Design in Drug Discovery
title_short Structural and Computational-Driven Molecule Design in Drug Discovery
title_sort structural and computational driven molecule design in drug discovery
topic SARS-CoV-2
COVID-19
drug repositioning
in silico studies
E protein
furan-1,3,4-oxadiazole
hTYR
hTYRP1
melanogenesis
molecular docking
MD simulations
substituted phenylacetic acid
Cu(II) carboxylates
DNA binding
enzymatic activity
antioxidant activity
bitter almond
EGFR
HER2
ADEMT
molecular dynamic
MM-PBSA
Pd(II) complexes
X-ray structure
antibacterial activity
antitumor activity
in silico study
benzofuran-1,3,4-oxadiazole
tuberclosis
Pks13 inhibitor
ADMET study
SAR
artificial intelligence
drug discovery
AI-assisted content generation
AI-limitations
galactosides
dengue virus
antimicrobial
dynamics
ADMET
chickpea
bioactive peptides
DPP-IV inhibitors
in silico
MRSA
shikimate pathway
dehydroquinate dehydratase
virtual screening
molecular dynamics
computer-aided drug design
AChE/BChE
Alzheimer’s disease
neurodegenerative disorders
antioxidants
donepezil
melatonin
neuroprotection
SH-SY5Y
Neuro-2a
BBB
MT1 and MT2
molecular dynamic simulations
acetylcholinesterase
zebrafish
hepatitis B virus
hepatitis C virus
(+)-catechin 3-gallate
?-sitosterol
KEGG
protein–protein interactions
cell-penetrating peptides
drug conjugates
biological membrane
penetratin
cyclic peptides
explicit membrane model
intracellular target
Desmond
in silico simulation
protein kinase
cancer
neurodegenerative diseases
covalent inhibitors
?-keto esters
DFT
docking
LasR and LuxS
quorum sensing
natural bioactive compounds
natural products
network pharmacology
ischemic stroke
flavonoids
terpenoids
analgesic
5-acetamido-2-hydroxy benzoic acid
ADME
toxicity
TRAF6
zinc finger
RING domain
X-ray crystallography
structural biology
Turkish light source “Turkish DeLight”
molecular modelling
pharmacokinetic determinants
human acetylcholinesterase
human butyrylcholinesterase
human beta-secretase 1
cytotoxic iridoids
dipole moment
QSAR
ligand-based design
bigel
Calophyllum inophyllum
calanolide A
piscean collagen
tamanu oil
drug design
novel molecules
encoder–decoder
transformer
quantitative estimate of drug-likeness (QED)
validity
reinforcement learning
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing
topic_facet SARS-CoV-2
COVID-19
drug repositioning
in silico studies
E protein
furan-1,3,4-oxadiazole
hTYR
hTYRP1
melanogenesis
molecular docking
MD simulations
substituted phenylacetic acid
Cu(II) carboxylates
DNA binding
enzymatic activity
antioxidant activity
bitter almond
EGFR
HER2
ADEMT
molecular dynamic
MM-PBSA
Pd(II) complexes
X-ray structure
antibacterial activity
antitumor activity
in silico study
benzofuran-1,3,4-oxadiazole
tuberclosis
Pks13 inhibitor
ADMET study
SAR
artificial intelligence
drug discovery
AI-assisted content generation
AI-limitations
galactosides
dengue virus
antimicrobial
dynamics
ADMET
chickpea
bioactive peptides
DPP-IV inhibitors
in silico
MRSA
shikimate pathway
dehydroquinate dehydratase
virtual screening
molecular dynamics
computer-aided drug design
AChE/BChE
Alzheimer’s disease
neurodegenerative disorders
antioxidants
donepezil
melatonin
neuroprotection
SH-SY5Y
Neuro-2a
BBB
MT1 and MT2
molecular dynamic simulations
acetylcholinesterase
zebrafish
hepatitis B virus
hepatitis C virus
(+)-catechin 3-gallate
?-sitosterol
KEGG
protein–protein interactions
cell-penetrating peptides
drug conjugates
biological membrane
penetratin
cyclic peptides
explicit membrane model
intracellular target
Desmond
in silico simulation
protein kinase
cancer
neurodegenerative diseases
covalent inhibitors
?-keto esters
DFT
docking
LasR and LuxS
quorum sensing
natural bioactive compounds
natural products
network pharmacology
ischemic stroke
flavonoids
terpenoids
analgesic
5-acetamido-2-hydroxy benzoic acid
ADME
toxicity
TRAF6
zinc finger
RING domain
X-ray crystallography
structural biology
Turkish light source “Turkish DeLight”
molecular modelling
pharmacokinetic determinants
human acetylcholinesterase
human butyrylcholinesterase
human beta-secretase 1
cytotoxic iridoids
dipole moment
QSAR
ligand-based design
bigel
Calophyllum inophyllum
calanolide A
piscean collagen
tamanu oil
drug design
novel molecules
encoder–decoder
transformer
quantitative estimate of drug-likeness (QED)
validity
reinforcement learning
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing
url ONIX_20240704_9783725810147_8